Back to Browse Journals » International Journal of Nephrology and Renovascular Disease » Volume 7

Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients

Authors Brunelli SM, Njord L, Hunt AE, Sibbel SP

Received 31 December 2013

Accepted for publication 13 February 2014

Published 3 April 2014 Volume 2014:7 Pages 131—139


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Steven M Brunelli,1 Levi Njord,2 Abigail E Hunt,1 Scott P Sibbel1

1DaVita Clinical Research®, Minneapolis, MN, USA; 2DaVita HealthCare Partners, Inc, Denver, CO, USA

Background and objectives: Catheter-related bloodstream infections (CRBSIs) are common in hemodialysis patients using central venous catheters, and catheter occlusion also occurs frequently. The Tego needlefree connector was developed to reduce the incidence of these complications; however, existing studies of its effectiveness and safety are limited.
Materials and methods: This retrospective analysis compared outcomes among patients of a large dialysis organization receiving in-center hemodialysis using a central venous catheter with either the Tego connector or standard catheter caps between October 1 and June 30, 2013. Incidence rates for intravenous (IV) antibiotic starts, receipt of an IV antibiotic course, positive blood cultures, mortality, and missed dialysis treatments were calculated, and incidence-rate ratios (IRRs) were estimated using Poisson regression models. Utilization of erythropoiesis-stimulating agents (ESAs) and thrombolytics was described for each patient-month and compared using mixed linear models. Models were run without adjustment, adjusted for covariates that were imbalanced between cohorts, or fully adjusted for all potential confounders.
Results: The analysis comprised 10,652 Tego patients and 6,493 controls. Tego use was independently associated with decreased risk of CRBSI, defined by initiation of IV antibiotics (adjusted IRR 0.92, 95% confidence interval [CI] 0.87–0.97) or initiation of IV antibiotic course (adjusted IRR 0.89, 95% CI 0.84–0.95). Tego use was independently associated with decreased rate of missed dialysis treatments (adjusted IRR 0.98, 95% CI 0.97–1.00); no significant difference between Tego and control cohorts was observed with respect to mortality. Tego use was associated with decreased likelihood of thrombolytic use (adjusted per-month probability of 5.6% versus 6.2% for controls) and lower utilization of ESAs in study months 7–9.
Conclusion: Use of the Tego connector may reduce the risk of CRBSI and result in lower utilization of thrombolytics, antibiotics, and ESAs, as well as fewer missed dialysis treatments.

Keywords: catheter, dialysis, end-stage renal disease, ESA, infection, mortality

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Readers of this article also read:

Rehabilitation for a child with recalcitrant anti-N-methyl-D-aspartate receptor encephalitis: case report and literature review

Guo YH, Kuan TS, Hsieh PC, Lien WC, Chang CK, Lin YC

Neuropsychiatric Disease and Treatment 2014, 10:2263-2267

Published Date: 24 November 2014

Placental tumor (chorioangioma) as a cause of polyhydramnios: a case report

Abdalla N, Bachanek M, Trojanowski S, Cendrowski K, Sawicki W

International Journal of Women's Health 2014, 6:955-959

Published Date: 20 November 2014

Antimicrobial nanocapsules: from new solvent-free process to in vitro efficiency

Steelandt J, Salmon D, Gilbert E, Almouazen E, Renaud FNR, Roussel L, Haftek M, Pirot F

International Journal of Nanomedicine 2014, 9:4467-4474

Published Date: 19 September 2014

Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia

Ugajin M, Yamaki K, Hirasawa N, Kobayashi T, Yagi T

International Journal of General Medicine 2013, 6:693-701

Published Date: 20 August 2013

Age as a factor in sensory integration function in Taiwanese children [Corrigendum]

Lin CK, Wu HM, Wang HY, Tseng MH, Lin CH

Neuropsychiatric Disease and Treatment 2013, 9:1221-1222

Published Date: 19 August 2013


Marusza W, Mlynarczyk G, Olszanski R, Netsvyetayeva I, Obrowski M, Iannitti T, Palmieri B

International Journal of Nanomedicine 2012, 7:4119-4120

Published Date: 27 July 2012

New and emerging treatments for the prevention of recurrent diverticulitis

Martin ST, Stocchi L

Clinical and Experimental Gastroenterology 2011, 4:203-212

Published Date: 19 September 2011